CN104547851B - One treats hypertensive medicine - Google Patents
One treats hypertensive medicine Download PDFInfo
- Publication number
- CN104547851B CN104547851B CN201410318315.0A CN201410318315A CN104547851B CN 104547851 B CN104547851 B CN 104547851B CN 201410318315 A CN201410318315 A CN 201410318315A CN 104547851 B CN104547851 B CN 104547851B
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- herba
- treatment
- paeoniae alba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 21
- 230000001631 hypertensive effect Effects 0.000 title claims abstract description 16
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241000269417 Bufo Species 0.000 claims abstract description 7
- 229910000960 colored gold Inorganic materials 0.000 claims abstract description 7
- 239000009806 pulsatillae Substances 0.000 claims abstract description 7
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 241000283956 Manis Species 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000002045 lasting effect Effects 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 8
- 239000012567 medical material Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 3
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses one and treat hypertensive medicine, make according to suitable proportioning primarily of following medicine: Rhizoma Gastrodiae, Ramulus Uncariae Cum Uncis, Radix Scutellariae, the Radix Paeoniae Alba, Radix Salviae Miltiorrhizae, the Cortex Eucommiae, Fructus Tribuli, Squama Manis, Semen Cassiae, Herba Euphorbiae Humifusae, Fructus Amomi, deep coloured gold, Bufo siccus, the Radix Pulsatillae, Herba Houttuyniae, Herba Violae, Bulbus Lilii.The present invention adopts several kinds of Chinese medicinal materials formulated, evident in efficacy to Hypertension disease, stable lasting, and treatment total effective rate is up to 99.2%, and rear without recurrence, has no side effect, relieves the trouble and worry of patient.
Description
Technical field
The present invention relates to one and treat hypertensive medicine, the medicine of specifically a kind of pure raw material of Chinese medicine preparation, belongs to Chinese medicine formula technical field.
Background technology
Hypertension is the modal cardiovascular disease in the world, and be also one of maximum epidemic diseases, often cause the complication of the internal organs such as the heart, brain, kidney, the health of the mankind in serious harm.Current China Hypertensive Population is more than 2.6 hundred million, and the sickness rate of hypertension in adult reaches 20%, but along with the raising of people's living standard, dietary structure collocation is unreasonable, and this ratio also has the trend risen.Clinical in hypertensive treatment, people widely use various Western medicine depressor, as antihypertensive drugs such as compound recipe reserpine, FUFANG JIANGYA PIAN, need long-term taking, have larger side effect to human body, and they can only take stopgap measures, can not effect a permanent cure.Chinese and Western medicine is compared, and side effect is obviously little, and curative effect is lasting.Also there are some in the market and treat hypertensive Chinese medicine, but its therapeutic effect is unsatisfactory.
Summary of the invention
Technical problem to be solved by this invention is to provide one and treats hypertensive medicine, and it can be used for treatment essential hypertension and secondary hypertension, and curative effect is high, instant effect, and safe without toxic side effect.
The technical solution used in the present invention is:
One treats hypertensive medicine, it is characterized in that, the raw material of following weight portion is adopted to make: Rhizoma Gastrodiae 8 ~ 12, Ramulus Uncariae Cum Uncis 10 ~ 14, Radix Scutellariae 8 ~ 12, the Radix Paeoniae Alba 8 ~ 12, Radix Salviae Miltiorrhizae 5-10, the Cortex Eucommiae 8 ~ 12, Fructus Tribuli 10-15, Squama Manis 5-10, Semen Cassiae 10-20, Radix Paeoniae Alba 10-15, Herba Euphorbiae Humifusae 5-10, Fructus Amomi 5-10, deep coloured gold 5-10, Bufo siccus 5-10, Radix Pulsatillae 5-10, Herba Houttuyniae 10-15, Herba Violae 8 ~ 12, Bulbus Lilii 5-10.
Said medicine can be made any one dosage form on pharmaceutics, as tablet, capsule, pill, granule, oral liquid or decoction.Preparation technique means well known in the art can be adopted to complete the preparation of medicament of the present invention.
Preferred dosage form of the present invention is capsule.Above medical material is joined by measuring, and pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
The invention has the beneficial effects as follows: formulated owing to have employed several kinds of Chinese medicinal materials, its goods include multi-medicament composition, evident in efficacy, stable lasting, can cure hypertension rapidly, and rear without recurrence, have no side effect, relieve the trouble and worry of patient.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details.
Embodiment 1
Hypertensive medicine is treated in the present embodiment, be made up of the raw material of following weight portion: Rhizoma Gastrodiae 10 g, Ramulus Uncariae Cum Uncis 12 g, Radix Scutellariae 10 g, the Radix Paeoniae Alba 10 g, Radix Salviae Miltiorrhizae 7 g, the Cortex Eucommiae 10 g, Fructus Tribuli 12 g, Squama Manis 8 g, Semen Cassiae 15 g, the Radix Paeoniae Alba 12 g, Herba Euphorbiae Humifusae 7 g, Fructus Amomi 7 g, deep coloured gold 8 g, Bufo siccus 8 g, the Radix Pulsatillae 7 g, Herba Houttuyniae 12 g, Herba Violae 10 g, Bulbus Lilii 6 g.Above medical material is joined by measuring, and pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Usage and consumption: every day 3 times, one time 2, taking 5 days is a course for the treatment of.
Embodiment 2
Hypertensive medicine is treated in the present embodiment, be made up of the raw material of following weight portion: Rhizoma Gastrodiae 8 g, Ramulus Uncariae Cum Uncis 10 g, Radix Scutellariae 8 g, the Radix Paeoniae Alba 8 g, Radix Salviae Miltiorrhizae 5 g, the Cortex Eucommiae 8 g, Fructus Tribuli 10 g, Squama Manis 5 g, Semen Cassiae 10 g, the Radix Paeoniae Alba 10 g, Herba Euphorbiae Humifusae 5 g, Fructus Amomi 5 g, deep coloured gold 5 g, Bufo siccus 5 g, the Radix Pulsatillae 5 g, Herba Houttuyniae 10 g, Herba Violae 8 g, Bulbus Lilii 5 g.Above medical material is joined by measuring, and pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Usage and consumption: every day 3 times, one time 2, taking 5 days is a course for the treatment of.
Embodiment 3
Hypertensive medicine is treated in the present embodiment, be made up of the raw material of following weight portion: Rhizoma Gastrodiae 9 g, Ramulus Uncariae Cum Uncis 11 g, Radix Scutellariae 11 g, the Radix Paeoniae Alba 11 g, Radix Salviae Miltiorrhizae 8 g, the Cortex Eucommiae 9 g, Fructus Tribuli 13 g, Squama Manis 6 g, Semen Cassiae 17 g, Radix Paeoniae Alba 13g, Herba Euphorbiae Humifusae 6 g, Fructus Amomi 7 g, deep coloured gold 8 g, Bufo siccus 6 g, the Radix Pulsatillae 8 g, Herba Houttuyniae 11 g, Herba Violae 9 g, Bulbus Lilii 7 g.Above medical material is joined by measuring, and pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Usage and consumption: every day 3 times, one time 2, taking 5 days is a course for the treatment of.
Embodiment 4
Hypertensive medicine is treated in the present embodiment, be made up of the raw material of following weight portion: Rhizoma Gastrodiae 12 g, Ramulus Uncariae Cum Uncis 14 g, Radix Scutellariae 12 g, the Radix Paeoniae Alba 12 g, Radix Salviae Miltiorrhizae 10 g, the Cortex Eucommiae 12 g, Fructus Tribuli 15 g, Squama Manis 10 g, Semen Cassiae 20 g, the Radix Paeoniae Alba 15 g, Herba Euphorbiae Humifusae 10 g, Fructus Amomi 10 g, deep coloured gold 10 g, Bufo siccus 10 g, the Radix Pulsatillae 10 g, Herba Houttuyniae 15 g, Herba Violae 12 g, Bulbus Lilii 10 g.Above medical material is joined by measuring, and pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Usage and consumption: every day 3 times, one time 2, taking 5 days is a course for the treatment of.
Test case
1, clinical data
Stochastic choice hyperpietic 130 example, observes the clinical effectiveness after using medicine of the present invention.Wherein man 55 example, female 75 example, 53 years old mean age.
2, diagnostic criteria
Western medicine diagnose standard: systolic pressure is equal to or higher than 140mmHg, diastolic pressure is equal to or higher than 90mmHg, both have one to examine, and can make a definite diagnosis.Differential diagnosis in tcm standard cardinal symptom: dizzy, headache, cardiopalmus, tinnitus, insomnia, agitation, waist soreness etc.
3, Therapeutic Method
Whole test case patient to take in the embodiment of the present invention 2 obtained medicine, 3 times on the one, one time 2.Within 5 days, be a course for the treatment of, after course for the treatment of medication, check blood pressure.
4, curative effect determinate standard
Cure: clinical symptoms all disappears, and blood pressure is down to normally, and does not recur in 1 year.Effective: clinical symptoms all disappears, after taking medicine, blood pressure declines to some extent but is not down to normal.Invalid: clinical symptoms does not change, before and after treatment, blood pressure does not obviously change.
5, the results are shown in Table 1 after case treatment.
Table 1 hypertension clinical treatment outcome
| Case load | Cure n(%) | Effective n(%) | Invalid n(%) | Total effective rate n(%) | |
| Test case | 130 | 121（93.1） | 8（6.1） | 1（0.8） | 129（99.2） |
Claims (3)
1. the hypertensive medicine for the treatment of, it is characterized in that, be made up of the raw material of following weight portion: Rhizoma Gastrodiae 8 ~ 12, Ramulus Uncariae Cum Uncis 10 ~ 14, Radix Scutellariae 8 ~ 12, the Radix Paeoniae Alba 8 ~ 12, Radix Salviae Miltiorrhizae 5-10, the Cortex Eucommiae 8 ~ 12, Fructus Tribuli 10-15, Squama Manis 5-10, Semen Cassiae 10-20, Radix Paeoniae Alba 10-15, Herba Euphorbiae Humifusae 5-10, Fructus Amomi 5-10, deep coloured gold 5-10, Bufo siccus 5-10, Radix Pulsatillae 5-10, Herba Houttuyniae 10-15, Herba Violae 8 ~ 12, Bulbus Lilii 5-10.
2. the hypertensive medicine for the treatment of according to claim 1, is characterized in that, the dosage form of described medicine is tablet, capsule, granule, pill, oral liquid or decoction.
3. the hypertensive medicine for the treatment of according to claim 1, is characterized in that, described medicine is capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410318315.0A CN104547851B (en) | 2014-07-07 | 2014-07-07 | One treats hypertensive medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410318315.0A CN104547851B (en) | 2014-07-07 | 2014-07-07 | One treats hypertensive medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104547851A CN104547851A (en) | 2015-04-29 |
| CN104547851B true CN104547851B (en) | 2015-09-30 |
Family
ID=53065622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410318315.0A Expired - Fee Related CN104547851B (en) | 2014-07-07 | 2014-07-07 | One treats hypertensive medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104547851B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110623971A (en) * | 2019-10-31 | 2019-12-31 | 广西中医药大学 | Application of anemonin B4 in preparation of medicine for lowering blood pressure |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1373190A (en) * | 2001-03-07 | 2002-10-09 | 陈列 | Process for preapring health-care lily bulb-dried ginger liquor |
| CN101890133A (en) * | 2010-07-09 | 2010-11-24 | 向文忠 | Medicine for lowering high blood pressure |
-
2014
- 2014-07-07 CN CN201410318315.0A patent/CN104547851B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1373190A (en) * | 2001-03-07 | 2002-10-09 | 陈列 | Process for preapring health-care lily bulb-dried ginger liquor |
| CN101890133A (en) * | 2010-07-09 | 2010-11-24 | 向文忠 | Medicine for lowering high blood pressure |
Non-Patent Citations (1)
| Title |
|---|
| 中药复方治疗高血压用药规律分析;孟凡珍等;《中成药》;20101231;第32卷(第12期);2195-2196 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104547851A (en) | 2015-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101612349B (en) | Medicine for treating coronary heart disease | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN103405719A (en) | Medicament for treatment of depression | |
| CN104547851B (en) | One treats hypertensive medicine | |
| CN104547523A (en) | Medicine for enhancing immunity and preparation method thereof | |
| CN101695527A (en) | Toxin-expelling intestine-moistening Chinese medicinal preparation and preparation method thereof | |
| CN103405602A (en) | Medicament for treating asthma | |
| CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
| CN105982906A (en) | Application of 20(R)-ginsenoside Rg3 in preparing medicines or health products capable of alleviating or/and treating rheumatoid diseases and medicines | |
| CN104225197A (en) | Traditional Chinese medicine for treating tinnitus cerebri caused by syndrome of qi depression transforming into fire | |
| CN104740094A (en) | Traditional Chinese medicine for treating migraine | |
| CN104173513B (en) | A kind of Chinese medicine or health product being used for the treatment of puerperal constipation | |
| CN104306676A (en) | Traditional Chinese medicine or health product for treating postnatal constipation | |
| CN102764325B (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN1306946C (en) | Snuffle dredging capsule | |
| CN105106682A (en) | Internal traditional Chinese medicine for treating hemorrhoids | |
| CN104623282A (en) | Traditional Chinese medicine healthy preparation for conditioning hypertension | |
| CN105362703A (en) | Traditional Chinese medicine composition for treating primary hypertension and preparation method thereof | |
| CN102319381B (en) | Chinese medicinal composition for treating primary hypertension | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN104208366A (en) | Chinese medicinal drug for treating marrow depletion and kidney deficiency syndrome tinnitus cerebri | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN102258657B (en) | Chinese medicinal composition for treating chronic colitis | |
| CN102028811B (en) | Traditional Chinese medicine composite used for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: CHEN QI Free format text: FORMER OWNER: JINAN SHUNJING PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20150817 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhao Yong Inventor after: Chen Qi Inventor after: Cui Fengyun Inventor before: Wang Qiangqiang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG QIANGQIANG TO: ZHAO YONG CHEN QI CUI FENGYUN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150817 Address after: 250022 Shandong city of Ji'nan province Duandian Road No. 217 Joint Logistics Department of the Ministry of health Applicant after: Chen Qi Address before: 250000 Shandong Province Flyover District of Ji'nan City Tian Jia Zhuang Road No. 6 Applicant before: Jinan Shun Jing Pharmaceutical Technology Co., Ltd |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150930 Termination date: 20160707 |